Skip to main content
Log in

Qualitative urinary organic acid analysis: 10 years of quality assurance

  • Original Article
  • Published:
Journal of Inherited Metabolic Disease

Abstract

Over the last 10 years, a total of 90 urine samples from patients with metabolic disorders and controls were circulated to different laboratories in Europe and overseas, starting with 67 laboratories in 2005 and reaching 101 in 2014. The participants were asked to analyse the samples in their usual way and to prepare a report as if to a non-specialist pediatrician. The performance for the detection of fumarase deficiency, glutaric aciduria type I, isovaleric aciduria, methylmalonic aciduria, mevalonic aciduria, phenylketonuria and propionic aciduria was excellent (98–100 %). Over the last few years, detection has clearly improved for tyrosinaemia type I (39 % in 2008 to over 80 % in 2011/2014), maple syrup urine disease (85 % in 2005 to 98 % in 2012), hawkinsinuria (62 % in 2010 to 88 % in 2014), aminoacylase I deficiency (43 % in 2009 to 73 % in 2012) and 3-methylcrotonyl-CoA carboxylase deficiency (60 % in 2005 to 93 % by 2011). Normal urines were mostly considered as normal (83–100 %), but laboratories often made additional diagnostic suggestions. When the findings were unambiguous, the reports were mostly clear. However, when they were less obvious, the content and quality of reports varied greatly. Repetition of organic acid measurements on a fresh sample was rarely suggested, while more complex or invasive diagnostic strategies, including further metabolic screening or biopsy were recommended. Surprisingly very few participants suggested referral from the general paediatrician to a specialist metabolic centre to confirm a diagnosis and, if applicable, to initiate treatment despite evidence suggesting that this improves the outcome for patients with inherited metabolic disorders. The reliability of qualitative organic acid analysis has improved over the last few years. However, several aspects of reporting to non-specialists may need discussion and clinicians need to be aware of the uncertainty inherent in all forms of laboratory diagnostic analysis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Bonham JR, Downing M, Pollitt RJ et al (1994) Quality assessment of urinary organic acid analysis. Ann Clin Biochem 31(Pt 2):129–133

    Article  PubMed  Google Scholar 

  • Engelke UF, Sass JO, Van Coster RN et al (2008) NMR spectroscopy of aminoacylase 1 deficiency, a novel inborn error of metabolism. NMR Biomed 21:138–147

    Article  CAS  PubMed  Google Scholar 

  • Heringer J, Boy SP, Ensenauer R et al (2010) Use of guidelines improves the neurological outcome in glutaric aciduria type I. Ann Neurol 68:743–752

    Article  PubMed  Google Scholar 

  • Hommes FA (1994) Quality control for selective screening of inborn errors of metabolism. Eur J Pediatr 153:S17–S22

    Article  CAS  PubMed  Google Scholar 

  • Peters V, Garbade SF, Langhans CD et al (2008) Qualitative urinary organic acid analysis: methodological approaches and performance. J Inherit Metab Dis 31:690–696

    Article  CAS  PubMed  Google Scholar 

  • Seashore MR (2001; Update: 2009) The organic acidemias: an overview. In: Pagon RA, Adam MP, Ardinger HH et al (eds) GeneReviews(R). University of Washington, Seattle

Download references

Acknowledgments

We thank Andrea Diers, Vera Schuhmann and Klaus Fischer for excellent technical assistance.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Verena Peters.

Ethics declarations

All procedures followed were in accordance with the ethical standards of the responsible committee on human studies (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000.

Informed consent

Informed consent was obtained from all patients or their legal guardians prior to study inclusion in countries where this was needed by law.

Animal rights

The article does not contain animal subjects

Conflict of interest

None.

Additional information

Communicated by: Eva Morava

Electronic supplementary material

Below is the link to the electronic supplementary material.

ESM 1

(DOC 28.0 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Peters, V., Bonham, J.R., Hoffmann, G.F. et al. Qualitative urinary organic acid analysis: 10 years of quality assurance. J Inherit Metab Dis 39, 683–687 (2016). https://doi.org/10.1007/s10545-016-9941-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10545-016-9941-1

Keywords

Navigation